Results 21 to 30 of about 261,219 (287)

87. Angiotensin II Type 2 Receptor Signal Modulation in Models of Cutaneous Wound Healing [PDF]

Plast Reconstr Surg Glob Open, 2023
Harrison J, Leong E, Marshall J, Bezuhly M.   +3 more
europepmc   +2 more sources

The Effect of a Nonpeptide Angiotensin II Type 2 Receptor Agonist, Compound 21, on Aortic Aneurysm Growth in a Mouse Model of Marfan Syndrome. [PDF]

J Cardiovasc Pharmacol, 2018
Introduction: Available evidence suggests that the renin–angiotensin–aldosterone (RAA) system is a good target for medical intervention on aortic root dilatation in Marfan syndrome (MFS).
Verbrugghe P, Verhoeven J, Clijsters M, Vervoort D, Schepens J, Meuris B, Herijgers P.   +6 more
europepmc   +2 more sources

Angiotensin II type 2 receptor-mediated dilation is greater in the cutaneous microvasculature of premenopausal women compared with men.

J Appl Physiol (1985), 2023
Schwartz KS, Lang JA, Stanhewicz AE.
europepmc   +3 more sources

Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trial. [PDF]

EClinicalMedicine, 2021
Tornling G, Batta R, Porter JC, Williams B, Bengtsson T, Parmar K, Kashiva R, Hallberg A, Cohrt AK, Westergaard K, Dalsgaard CJ, Raud J.   +11 more
europepmc   +3 more sources

THE EFFICACY OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANTAGONISTS OF THE RECEPTORS OF THE 1ST TYPE OF ANGIOTENSIN II IN PATIENTS WITH CORONARY ARTERY DISEASE POSTINFARCTION CARDIOSCLEROSIS COMBINED WITH DIABETES MELLITUS TYPE 2 AND ARTERIAL HYPERTENSION

В мире научных открытий, 2016
The article discusses the effectiveness of 3-month therapy with angiotensin converting enzyme inhibitors fosinopril receptor and antagonists of the angiotensin II valsartan to achieve target BP(
Zarina Vyacheslavovna Bitarovа, Oleg Valeryevich Remizov, Zamira Tatarbekovna Astakhova, Zalina Aslanbekovna Toguzova   +3 more
doaj   +2 more sources

Investigation of the effect of the angiotensin II type 2 receptor (AT2R) agonist C21 on plasma NT-proBNP, a diagnostic biomarker, in subjects hospitalised with COVID-19 [PDF]

Eur Heart J, 2022
Rohit Batta, Göran Tornling, E. Rosendahl, T Bengtsson, Johan Raud   +4 more
europepmc   +3 more sources

Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer [PDF]

Journal of Experimental & Clinical Cancer Research, 2017
Background Bladder cancer (BCa) is the ninth most common form of cancer in the world. There is a continuing need not only for improving the accuracy of diagnostic markers but also for the development of new treatment strategies. Recent studies have shown
Nana Pei, Yingying Mao, Pengfei Wan, Xinglu Chen, Andrew Li, Huiying Chen, Jinlong Li, Renqiang Wan, Yanling Zhang, Hongyan Du, Baihong Chen, Guangyu Jiang, Minghan Xia, Colin Sumners, Guixue Hu, Dongsheng Gu, Hongwei Li   +16 more
doaj   +2 more sources

Effects of compound 21, a non‑peptide angiotensin II type 2 receptor agonist, on general anesthesia‑induced cerebral injury in neonatal rats. [PDF]

Mol Med Rep, 2018
Yong J, Yan L, Wang J, Xiao H, Zeng Q.
europepmc   +3 more sources

Angiotensin II Type 2 Receptor and Receptor Mas Are Colocalized and Functionally Interdependent in Obese Zucker Rat Kidney. [PDF]

Hypertension, 2017
Patel SN, Ali Q, Samuel P, Steckelings UM, Hussain T.   +4 more
europepmc   +2 more sources

Differential Regulation of Intracisternally Injected Angiotensin II-Induced Mechanical Allodynia and Thermal Hyperalgesia in Rats

Biomedicines, 2023
The present study examined the underlying mechanisms of mechanical allodynia and thermal hyperalgesia induced by the intracisternal injection of angiotensin (Ang) II.
Ki-Don Park, Jo-Young Son, Hak-Kyun Kim, Yu-Mi Kim, Jin-Sook Ju, Min-Jeong Jo, Min-Kyoung Park, Min-Kyung Lee, Dong-Kuk Ahn   +8 more
doaj   +1 more source